Report Overview
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
The global Bone Morphogenetic Protein (BMP) 2 market size is projected to grow from US$ 682 million in 2024 to US$ 1160 million in 2030; it is expected to grow at a CAGR of 9.2% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Bone Morphogenetic Protein (BMP) 2 Industry Forecast” looks at past sales and reviews total world Bone Morphogenetic Protein (BMP) 2 sales in 2022, providing a comprehensive analysis by region and market sector of projected Bone Morphogenetic Protein (BMP) 2 sales for 2023 through 2029. With Bone Morphogenetic Protein (BMP) 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Morphogenetic Protein (BMP) 2 industry.
This Insight Report provides a comprehensive analysis of the global Bone Morphogenetic Protein (BMP) 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bone Morphogenetic Protein (BMP) 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Morphogenetic Protein (BMP) 2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Morphogenetic Protein (BMP) 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Morphogenetic Protein (BMP) 2.
Global core manufacturers of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering and Cellumed. North America is the largest consumption region, accounting for approximately 69% of the global market, followed by Asia-Pacific. In terms of product type, sponge is the largest market segment, with a share of more than 81%. In terms of application, the largest application is spinal fusion, with a share of approximately 68%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone Morphogenetic Protein (BMP) 2 market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sponge
Gel
Segmentation by Application:
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
reconstructive surgery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Sponge
Gel
Segmentation by Application:
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
reconstructive surgery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Jiuyuan Gene Engineering
Cellumed
Table Of Contents
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2017-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Bone Morphogenetic Protein (BMP) 2 Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Bone Morphogenetic Protein (BMP) 2 Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Bone Morphogenetic Protein (BMP) 2 Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by region)
5 Global Bone Morphogenetic Protein (BMP) 2 Market-Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3
6 Global Bone Morphogenetic Protein (BMP) 2 Market-Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
7 Global Bone Morphogenetic Protein (BMP) 2 Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence A Company Profiles
8.1 Company 1
8.1.1 Company 1 Profile
8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023
8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis
8.1.4 Company 1 Business Overview/Recent Development/Acquisitions
8.2 Company 2
8.2.1 Company 2 Profile
8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023
8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis
8.2.4 Company 2 Business Overview/Recent Development/Acquisitions
8.3 Company 3
8.3.1 Company 3 Profile
8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023
8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis
8.3.4 Company 3 Business Overview/Recent Development/Acquisitions
8.4 Company 4
8.4.1 Company 4 Profile
8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023
8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis
8.4.4 Company 4 Business Overview/Recent Development/Acquisitions
8.5 Company 5
8.5.1 Company 5 Profile
8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023
8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis
8.5.4 Company 5 Business Overview/Recent Development/Acquisitions
8.6 Company 6
8.6.1 Company 6 Profile
8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023
8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis
8.6.4 Company 6 Business Overview/Recent Development/Acquisitions
8.7 Company 7
8.7.1 Company 7 Profile
8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023
8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis
8.7.4 Company 7 Business Overview/Recent Development/Acquisitions
8.8 Company 8
8.8.1 Company 8 Profile
8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023
8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis
8.8.4 Company 8 Business Overview/Recent Development/Acquisitions
8.9 Company 9
8.9.1 Company 9 Profile
8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023
8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis
8.9.4 Company 9 Business Overview/Recent Development/Acquisitions
8.10 Company 10
8.10.1 Company 10 Profile
8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023
8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis
8.10.4 Company 10 Business Overview/Recent Development/Acquisitions
8.11 Company 11
8.11.1 Company 11 Profile
8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023
8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis
8.11.4 Company 11 Business Overview/Recent Development/Acquisitions
8.12 Company 12
8.12.1 Company 12 Profile
8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023
8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis
8.12.4 Company 12 Business Overview/Recent Development/Acquisitions
8.13 Company 13
8.13.1 Company 13 Profile
8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023
8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis
8.13.4 Company 13 Business Overview/Recent Development/Acquisitions
8.14 Company 14
8.14.1 Company 14 Profile
8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023
8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis
8.14.4 Company 14 Business Overview/Recent Development/Acquisitions
8.15 Company 15
8.15.1 Company 15 Profile
8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023
8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis
8.15.4 Company 15 Business Overview/Recent Development/Acquisitions
9 Global Bone Morphogenetic Protein (BMP) 2 Market-Segmentation by Geography
10 North America
10.1 North America Bone Morphogenetic Protein (BMP) 2 Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
10.2 North America Bone Morphogenetic Protein (BMP) 2 Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
10.3 North America Bone Morphogenetic Protein (BMP) 2 Production Analysis from 2017-2023
10.4 North America Bone Morphogenetic Protein (BMP) 2 Consumption Analysis from 2017-2023
10.5 North America Bone Morphogenetic Protein (BMP) 2 Import and Export from 2017-2023
10.6 North America Bone Morphogenetic Protein (BMP) 2 Value, Production and Market Share by Type (2017-2023)
10.7 North America Bone Morphogenetic Protein (BMP) 2 Consumption, Value and Market Share by Application (2017-2023)
10.8 North America Bone Morphogenetic Protein (BMP) 2 by Country (United States, Canada)
10.8.1 North America Bone Morphogenetic Protein (BMP) 2 Sales by Country (2017-2023)
10.8.2 North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2017-2023)
10.9 North America Bone Morphogenetic Protein (BMP) 2 Market PEST Analysis
11 Europe
11.1 Europe Bone Morphogenetic Protein (BMP) 2 Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
11.2 Europe Bone Morphogenetic Protein (BMP) 2 Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
11.3 Europe Bone Morphogenetic Protein (BMP) 2 Production Analysis from 2017-2023
11.4 Europe Bone Morphogenetic Protein (BMP) 2 Consumption Analysis from 2017-2023
11.5 Europe Bone Morphogenetic Protein (BMP) 2 Import and Export from 2017-2023
11.6 Europe Bone Morphogenetic Protein (BMP) 2 Value, Production and Market Share by Type (2017-2023)
11.7 Europe Bone Morphogenetic Protein (BMP) 2 Consumption, Value and Market Share by Application (2017-2023)
11.8 Europe Bone Morphogenetic Protein (BMP) 2 by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Bone Morphogenetic Protein (BMP) 2 Sales by Country (2017-2023)
11.8.2 Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2017-2023)
11.9 Europe Bone Morphogenetic Protein (BMP) 2 Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
12.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
12.3 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Production Analysis from 2017-2023
12.4 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Analysis from 2017-2023
12.5 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Import and Export from 2017-2023
12.6 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Value, Production and Market Share by Type (2017-2023)
12.7 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption, Value and Market Share by Application (2017-2023)
12.8 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Sales by Country (2017-2023)
12.8.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2017-2023)
12.9 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market PEST Analysis
13 Latin America
13.1 Latin America Bone Morphogenetic Protein (BMP) 2 Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
13.2 Latin America Bone Morphogenetic Protein (BMP) 2 Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
13.3 Latin America Bone Morphogenetic Protein (BMP) 2 Production Analysis from 2017-2023
13.4 Latin America Bone Morphogenetic Protein (BMP) 2 Consumption Analysis from 2017-2023
13.5 Latin America Bone Morphogenetic Protein (BMP) 2 Import and Export from 2017-2023
13.6 Latin America Bone Morphogenetic Protein (BMP) 2 Value, Production and Market Share by Type (2017-2023)
13.7 Latin America Bone Morphogenetic Protein (BMP) 2 Consumption, Value and Market Share by Application (2017-2023)
13.8 Latin America Bone Morphogenetic Protein (BMP) 2 by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Bone Morphogenetic Protein (BMP) 2 Sales by Country (2017-2023)
13.8.2 Latin America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2017-2023)
13.9 Latin America Bone Morphogenetic Protein (BMP) 2 Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
14.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
14.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Production Analysis from 2017-2023
14.4 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Analysis from 2017-2023
14.5 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Import and Export from 2017-2023
14.6 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Value, Production and Market Share by Type (2017-2023)
14.7 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption, Value and Market Share by Application (2017-2023)
14.8 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Sales by Country (2017-2023)
14.8.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2017-2023)
14.9 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market PEST Analysis
15 Future Forecast of the Global Bone Morphogenetic Protein (BMP) 2 Market from 2023-2029
15.1 Future Forecast of the Global Bone Morphogenetic Protein (BMP) 2 Market from 2023-2029 Segment by Region
15.2 Global Bone Morphogenetic Protein (BMP) 2 Production and Growth Rate Forecast by Type (2023-2029)
15.3 Global Bone Morphogenetic Protein (BMP) 2 Consumption and Growth Rate Forecast by Application (2023-2029)
16 Appendix
16.1 Methodology
16.2 Research Data Source